MYNERVA AG
PrivateLast Round
Grant
Oct 31, 2025
Total Funding Raised
$5.96M
Company Overview
MYNERVA AG operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Grant round in October 2025.
MYNERVA AG is a medical device company that develops wearable neuro-robotic technology to reduce chronic pain and restore the sense of touch in patients with diabetic peripheral neuropathy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MYNERVA AG Comparables
Compare MYNERVA AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Walk With Path | 81% | |
| RxFunction | 79% | |
| SensArs Neuroprosthetics | 72% |
For institutional investors. Book with your work email.
MYNERVA AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 31, 2025 | ||||
| Grant | Jun 23, 2025 | ||||
| Seed | Sep 1, 2024 | ||||
| Grant | Nov 24, 2023 | ||||
| Grant | Sep 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MYNERVA AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Diabetes Center Berne | Grant |
| MassChallenge Switzerland | Grant |
| Future of Health Grant | Grant |
| >>venture>> Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 9, 2026
Grew 33% QoQ from 12 to 16 employees.
- Dec 23, 2025
Grew 30% QoQ from 10 to 13 employees.
For institutional investors. Book with your work email.
MYNERVA AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MYNERVA AG's valuation, stock price, and market status.
Is MYNERVA AG a public or private company?
MYNERVA AG is a private company.
What is the current stock price of MYNERVA AG?
MYNERVA AG is a private company, so its shares have no public market price. Caplight tracks MYNERVA AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MYNERVA AG worth (valuation)?
Valuation information for MYNERVA AG is not publicly available.
Can I buy MYNERVA AG stock?
MYNERVA AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MYNERVA AG's last funding round?
MYNERVA AG's most recent funding round was Grant on October 31, 2025.
Who are the main investors in MYNERVA AG?
Key investors in MYNERVA AG include Diabetes Center Berne, MassChallenge Switzerland, Future of Health Grant, >>venture>> Foundation.
Will MYNERVA AG IPO soon?
No public IPO plans have been announced for MYNERVA AG.
How can I track MYNERVA AG secondary market activity?
Caplight tracks bids, offers, and trades in MYNERVA AG's shares on secondary markets.